Department of Clinical Pharmacy Practice, College of Pharmacy and Allied Health Professions, St. John's University, Queens, NY, USA.
Ann Pharmacother. 2009 Dec;43(12):2001-11. doi: 10.1345/aph.1M557. Epub 2009 Nov 17.
To review the pathophysiology, pandemics/epidemics, transmissibility, clinical presentation, treatment, prevention/immunization, and resistance associated with seasonal, avian, and swine influenza.
Literature was obtained from MEDLINE (1966-October 2009) and International Pharmaceutical Abstracts (1971-October 2009) using the search terms influenza, seasonal influenza, avian influenza, swine influenza, H1N1, novel H1N1, H3N2, and H5N1.
Available English-language articles were reviewed, along with information obtained from the Centers for Disease Control and Prevention, the Food and Drug Administration, and the World Health Organization.
The influenza virus has caused disease in birds, swine, and humans for many centuries. Pandemics and epidemics have occurred throughout history and reports of new strains continue to emerge. Two major surface antigenic glycoproteins, hemagglutinin and neuraminidase, have various subtypes, resulting in numerous combinations of these proteins. For example, combinations occur when an influenza strain from a bird "mixes" with a strain from a human. This mixing occurs in a host, often in pigs, resulting in a new strain. This new strain can cause pandemics since people have no immunity to the new strain. An H1N1 subtype pandemic occurred in 1918, causing millions of deaths. Simultaneously, veterinary reports of "influenza" in pigs also emerged. It is postulated that humans infected pigs with this H1N1 virus. H1N1 reappeared in humans in 1976, and more recently in 2009. Other pandemics have occurred with H2N2 and H3N2 strains. In 1997, strain H5N1, which usually causes disease in fowl, was able to infect humans.
Influenza subtypes continue to change, causing disease in animals and humans. Utilization of immunization and antiviral treatment options are available to prevent, treat, and contain the spread of this infection.
综述季节性流感、禽流感和猪流感的病理生理学、大流行/流行情况、传染性、临床表现、治疗、预防/免疫和耐药性。
使用“流感、季节性流感、禽流感、猪流感、H1N1、新型 H1N1、H3N2 和 H5N1”等检索词,检索 MEDLINE(1966 年-2009 年 10 月)和国际药学文摘(1971 年-2009 年 10 月)中的文献。
对可获得的英文文章进行了综述,并查阅了美国疾病控制与预防中心、美国食品和药物管理局以及世界卫生组织的相关信息。
流感病毒在鸟类、猪和人类中引起疾病已达数个世纪之久。在历史上,大流行和流行不断发生,新菌株的报告仍在不断出现。两种主要的表面抗原糖蛋白——血凝素和神经氨酸酶——具有多种亚型,导致这些蛋白的组合种类繁多。例如,当一种来自禽类的流感株“混合”来自人类的株时,就会发生组合。这种混合发生在宿主(通常是猪)体内,导致新的菌株出现。由于人们对新菌株没有免疫力,这种新菌株可能会引发大流行。1918 年发生的 H1N1 亚型大流行导致数百万人死亡。同时,兽医也报告了猪的“流感”病例。据推测,人类将这种 H1N1 病毒传染给了猪。1976 年 H1N1 再次出现在人类中,最近又在 2009 年出现。其他大流行则与 H2N2 和 H3N2 株有关。1997 年,通常导致禽类发病的 H5N1 株能够感染人类。
流感亚型继续发生变化,导致动物和人类发病。利用免疫接种和抗病毒治疗方案,可以预防、治疗和控制这种感染的传播。